Pharm Made Easy 3.0- Musculoskeletal Updated
Exam 2026 WITH Recent Newest Verified And
Well Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions) ALREADY
GRADED A+||NEWEST VERSION Of The Exam
Guarantee Pass!!
A health care professional is caring for a patient who is taking alendronate (Fosamax) to
treat postmenopausal osteoporosis. The health care professional should explain to the
patient that alendronate increases bone mass by which of the following actions?
A. Decreases activity of osteoclasts
B. Increases calcium excretion
C. Promotes intestinal absorption of calcium and phosphorus
D. Reduces action of osteoblasts - ANSWERS-A. Decreases activity of osteoclasts
Osteoclasts are cells that cause bone resorption or bone loss. Alendronate reduces the
activity of osteoclasts, reducing bone loss and increasing bone mass.
A health care professional is administering succinylcholine (Anectine) to a patient.
Which of the following information is correct regarding depolarizing neuromuscular
blocking agents?
A. Reverses with a cholinesterase inhibitor, such as neostigmine (Prostigmin)
B. Causes muscle paralysis by binding with cholinergic receptors at the neuromuscular
junction
C. Prevents the nerve from depolarizing, and the skeletal muscle from contracting
D. Blocks acetylcholine from binding with cholinergic receptors at the motor endplate -
ANSWERS-B. Causes muscle paralysis by binding with cholinergic receptors at the
neuromuscular junction
, Succinylcholine, a depolarizing muscle relaxant, mimics acetylcholine (Miochol-E) by
binding with the cholinergic receptors at the neuromuscular junction.
Which of the following is a therapeutic action of raloxifene (Evista)?
A. Blocks the effects of estrogen on endometrial tissue
B. Mimics the effects of estrogen on bone tissue
C. Stimulates secretion of parathyroid hormone
D. Stimulates mensuration - ANSWERS-B. Mimics the effects of estrogen on bone
tissue.Raloxifene mimics the effects of estrogen on bone tissue, minimizing or stopping
bone loss.
A health care professional is preparing to administer neostigmine (Prostigmin) to a
patient who has myasthenia gravis. Knowing the adverse effects of neostigmine, which
of the following drugs should the health care professional have ready to administer?
A. Atropine (AtroPen)
B. Lidocaine (Xylocaine)
C. Epinephrine (Adrenalin)
D. Naloxone - ANSWERS-A. Atropine
It is important to have atropine, an anticholinergic, available to reverse bradycardia that
can result from the administration of neostigmine, a cholinesterase inhibitor.
A health care professional should tell a patient who is taking etanercept (Enbril) for
rheumatoid arthritis to report which of the following?
A. Skin rash
B. Tinnitus
C. Diarrhea
D. Dysphagia - ANSWERS-A. Skin rash
Etanercept can cause serious skin infections, such as Stevens-Johnson syndrome and
toxic epidermal necrolysis. Patients should report any skin rashes or blisters
immediately.
Exam 2026 WITH Recent Newest Verified And
Well Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions) ALREADY
GRADED A+||NEWEST VERSION Of The Exam
Guarantee Pass!!
A health care professional is caring for a patient who is taking alendronate (Fosamax) to
treat postmenopausal osteoporosis. The health care professional should explain to the
patient that alendronate increases bone mass by which of the following actions?
A. Decreases activity of osteoclasts
B. Increases calcium excretion
C. Promotes intestinal absorption of calcium and phosphorus
D. Reduces action of osteoblasts - ANSWERS-A. Decreases activity of osteoclasts
Osteoclasts are cells that cause bone resorption or bone loss. Alendronate reduces the
activity of osteoclasts, reducing bone loss and increasing bone mass.
A health care professional is administering succinylcholine (Anectine) to a patient.
Which of the following information is correct regarding depolarizing neuromuscular
blocking agents?
A. Reverses with a cholinesterase inhibitor, such as neostigmine (Prostigmin)
B. Causes muscle paralysis by binding with cholinergic receptors at the neuromuscular
junction
C. Prevents the nerve from depolarizing, and the skeletal muscle from contracting
D. Blocks acetylcholine from binding with cholinergic receptors at the motor endplate -
ANSWERS-B. Causes muscle paralysis by binding with cholinergic receptors at the
neuromuscular junction
, Succinylcholine, a depolarizing muscle relaxant, mimics acetylcholine (Miochol-E) by
binding with the cholinergic receptors at the neuromuscular junction.
Which of the following is a therapeutic action of raloxifene (Evista)?
A. Blocks the effects of estrogen on endometrial tissue
B. Mimics the effects of estrogen on bone tissue
C. Stimulates secretion of parathyroid hormone
D. Stimulates mensuration - ANSWERS-B. Mimics the effects of estrogen on bone
tissue.Raloxifene mimics the effects of estrogen on bone tissue, minimizing or stopping
bone loss.
A health care professional is preparing to administer neostigmine (Prostigmin) to a
patient who has myasthenia gravis. Knowing the adverse effects of neostigmine, which
of the following drugs should the health care professional have ready to administer?
A. Atropine (AtroPen)
B. Lidocaine (Xylocaine)
C. Epinephrine (Adrenalin)
D. Naloxone - ANSWERS-A. Atropine
It is important to have atropine, an anticholinergic, available to reverse bradycardia that
can result from the administration of neostigmine, a cholinesterase inhibitor.
A health care professional should tell a patient who is taking etanercept (Enbril) for
rheumatoid arthritis to report which of the following?
A. Skin rash
B. Tinnitus
C. Diarrhea
D. Dysphagia - ANSWERS-A. Skin rash
Etanercept can cause serious skin infections, such as Stevens-Johnson syndrome and
toxic epidermal necrolysis. Patients should report any skin rashes or blisters
immediately.
